Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivity.

Jamieson PJ, Shen X, Abu-Shmais AA, Wasdin PT, Janowska K, Edwards RJ, Scapellato G, Bukenya M, Bass LE, Richardson SI, Manamela NP, Liu S, Barr M, Adams L, Paola Velez-Castro C, McCarthy C, Alexander CA, Gillespie RA, Mimms J, Suryadevara N, Sornberger TA, Zost SJ, Parks R, Flaherty S, Janke AK, Howard BN, Suresh YP, Ruprecht RM, Crowe JE Jr, Carnahan RH, Bailey JR, Kanekiyo M, Lingwood D, Haynes BF, Moore PL, Bonami RH, Tomaras GD, Archarya P, Montefiori DC, Kalams SA, Lu S, Georgiev IS

Open source

DOI: 10.1128/jvi.01256-25
Published: 2025 Dec 23
Container: Journal of virology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1128/jvi.01256-25,
  title = {Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivity.},
  author = {Jamieson PJ and Shen X and Abu-Shmais AA and Wasdin PT and Janowska K and Edwards RJ and Scapellato G and Bukenya M and Bass LE and Richardson SI and Manamela NP and Liu S and Barr M and Adams L and Paola Velez-Castro C and McCarthy C and Alexander CA and Gillespie RA and Mimms J and Suryadevara N and Sornberger TA and Zost SJ and Parks R and Flaherty S and Janke AK and Howard BN and Suresh YP and Ruprecht RM and Crowe JE Jr and Carnahan RH and Bailey JR and Kanekiyo M and Lingwood D and Haynes BF and Moore PL and Bonami RH and Tomaras GD and Archarya P and Montefiori DC and Kalams SA and Lu S and Georgiev IS},
  year = {2025},
  journal = {Journal of virology},
  doi = {10.1128/jvi.01256-25},
  url = {https://doi.org/10.1128/jvi.01256-25}
}

RIS

TY  - JOUR
TI  - Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivity.
AU  - Jamieson PJ
AU  - Shen X
AU  - Abu-Shmais AA
AU  - Wasdin PT
AU  - Janowska K
AU  - Edwards RJ
AU  - Scapellato G
AU  - Bukenya M
AU  - Bass LE
AU  - Richardson SI
AU  - Manamela NP
AU  - Liu S
AU  - Barr M
AU  - Adams L
AU  - Paola Velez-Castro C
AU  - McCarthy C
AU  - Alexander CA
AU  - Gillespie RA
AU  - Mimms J
AU  - Suryadevara N
AU  - Sornberger TA
AU  - Zost SJ
AU  - Parks R
AU  - Flaherty S
AU  - Janke AK
AU  - Howard BN
AU  - Suresh YP
AU  - Ruprecht RM
AU  - Crowe JE Jr
AU  - Carnahan RH
AU  - Bailey JR
AU  - Kanekiyo M
AU  - Lingwood D
AU  - Haynes BF
AU  - Moore PL
AU  - Bonami RH
AU  - Tomaras GD
AU  - Archarya P
AU  - Montefiori DC
AU  - Kalams SA
AU  - Lu S
AU  - Georgiev IS
PY  - 2025
JO  - Journal of virology
DO  - 10.1128/jvi.01256-25
UR  - https://doi.org/10.1128/jvi.01256-25
ER  -

APA

PJ, J., X, S., AA, A., PT, W., K, J., RJ, E., G, S., M, B., LE, B., SI, R., NP, M., S, L., M, B., L, A., C, P. V., C, M., CA, A., RA, G., J, M., N, S., TA, S., SJ, Z., R, P., S, F., AK, J., BN, H., YP, S., RM, R., Jr, C. J., RH, C., JR, B., M, K., D, L., BF, H., PL, M., RH, B., GD, T., P, A., DC, M., SA, K., S, L., & IS, G. (2025). Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivity.. Journal of virology. https://doi.org/10.1128/jvi.01256-25

Source records

pubmed · retrieved 2026-09-27T09:40:18.746Z